STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, ...

Veteran immunologist and former Pfizer R&D leader joins Circurna to advance its circular RNA therapeutic platform ...

A giant impact on the early Earth could have brought the building blocks of RNA to our planet, which new research suggests ...

STORM Therapeutics has entered a new collaboration with US‑based AlidaBio to accelerate the development of cancer therapies that target RNA modifications.

Biologists mapping the human microbiome expected to find new bacteria and viruses, not entities that slip through every ...

Scientists have discovered a new CRISPR mechanism with precise activity, expanding the potential applications of the existing ...

Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...

New research provides a mechanistic map of how genetic mutations disrupt RNA splicing in acute myeloid leukemia.

A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...

Seeing plastic trash while hiking inspired a Rutgers chemist to rethink why synthetic plastics last forever while natural ...

The CRISPR “gene scissors” have become an important basis for genome-editing technologies in many fields, ranging from biology and medicine to agriculture and industry. A team from the Helmholtz ...

Life on Earth began in a world of volcanic eruptions, violent storms, and a toxic atmosphere. Yet somehow, from this chaos, ...